Article
AbbVie posts weak sales of newer drugs as Humira faces fresh competition, shares fall
Rating:
0.0
Views:
59
Likes:
1
Library:
1
AbbVie Inc on Thursday missed quarterly revenue estimates for its newer treatments, fueling concerns over the drugmaker's attempts to cushion the blow to sales from fresh competition for its flagship arthritis drug Humira.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value